Skip to content

Study on the Correlation Between Heparanase (HPSE) and Myocardial Ischemia-Reperfusion Injury

Study on the Correlation Between Heparanase (HPSE) and Myocardial Ischemia-Reperfusion Injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101275
Enrollment
Unknown
Registered
2025-04-23
Start date
2025-04-23
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Ischemia-Reperfusion Injury

Interventions

Patients with Acute Coronary Occlusion Undergoing Reperfusion:no
Individuals with Normal Hemodynamic Parameters on Coronary Angiography:no

Sponsors

The 960th hospital of the Joint Logistics Support Force of the People’s Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Experimental Group (Patients with Acute Coronary Occlusion Undergoing Reperfusion) 1. Meeting diagnostic criteria for acute coronary occlusion. 2. Emergency PCI confirmed at least one major coronary artery with complete occlusion (TIMI flow grade 0). 3. Successful reperfusion post-emergency PCI with restored TIMI flow grade 1–3 in the occluded vessel. 4. Patients or their legal guardians provided written informed consent for study participation. Control Group (Individuals with Normal Hemodynamic Parameters on Coronary Angiography) 1. Coronary angiography showing no significant stenosis (luminal stenosis <30%) and TIMI flow grade 3. 2. No history of myocardial infarction or other severe cardiovascular diseases. 3. Patients provided written informed consent for study participation.

Exclusion criteria

Exclusion criteria: Exclusion criteria included any of the following: 1. Severe cardiovascular diseases, hepatic or renal dysfunction, malignant tumors. 2. Hypersensitivity to the investigational drug or related medications, or recent use of drugs that may affect HPSE levels. 3. Recent percutaneous coronary intervention (PCI) or other cardiac surgeries. 4. Pregnancy or lactation, psychiatric or neurological disorders, or inability to cooperate and complete the study. Participants meeting any one of the above criteria were excluded.

Design outcomes

Primary

MeasureTime frame
Heparanase;

Secondary

MeasureTime frame
N-terminal pro-B-type natriuretic peptide;Low-Density Lipoprotein;

Countries

China

Contacts

Public ContactQun Jin

The 960th hospital of the Joint Logistics Support Force of the People’s Liberation Army

jinqun1998@163.com+86 138 6400 3305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026